HEADER IMMUNE SYSTEM 22-MAY-18 6GL3
TITLE CRYSTAL STRUCTURE OF HUMAN PHOSPHATIDYLINOSITOL 4-KINASE III BETA
TITLE 2 (PI4KIIIBETA) IN COMPLEX WITH LIGAND 44
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 4-KINASE BETA,PHOSPHATIDYLINOSITOL 4-
COMPND 3 KINASE BETA;
COMPND 4 CHAIN: A, B;
COMPND 5 SYNONYM: PTDINS 4-KINASE BETA,NPIK,PI4K92,PTDINS 4-KINASE BETA,NPIK,
COMPND 6 PI4K92;
COMPND 7 EC: 2.7.1.67,2.7.1.67;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PI4KB, PIK4CB;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108
KEYWDS PI4K KINASE, IMMUNOSUPPRESSIVE, PHOSPHOINOSITOL 4-KINASE IIIBETA,
KEYWDS 2 TRANSPLANTATION, HUMAN MIXED LYMPHOCYTE REACTION, SELECTIVITY
KEYWDS 3 PROFILE, BINDING MODE, SOLUBILITY, IMMUNE SYSTEM
EXPDTA X-RAY DIFFRACTION
AUTHOR A.LAMMENS,M.AUGUSTIN,S.STEINBACHER,J.REUBERSON
REVDAT 3 15-MAY-24 6GL3 1 REMARK
REVDAT 2 22-AUG-18 6GL3 1 JRNL
REVDAT 1 15-AUG-18 6GL3 0
JRNL AUTH J.REUBERSON,H.HORSLEY,R.J.FRANKLIN,D.FORD,J.NEUSS,
JRNL AUTH 2 D.BROOKINGS,Q.HUANG,B.VANDERHOYDONCK,L.J.GAO,M.Y.JANG,
JRNL AUTH 3 P.HERDEWIJN,A.GHAWALKAR,F.FALLAH-ARANI,A.R.KHAN,J.HENSHALL,
JRNL AUTH 4 M.JAIRAJ,S.MALCOLM,E.WARD,L.SHUTTLEWORTH,Y.LIN,S.LI,T.LOUAT,
JRNL AUTH 5 M.WAER,J.HERMAN,A.PAYNE,T.CESKA,C.DOYLE,W.PITT,M.CALMIANO,
JRNL AUTH 6 M.AUGUSTIN,S.STEINBACHER,A.LAMMENS,R.ALLEN
JRNL TITL DISCOVERY OF A POTENT, ORALLY BIOAVAILABLE PI4KIII BETA
JRNL TITL 2 INHIBITOR (UCB9608) ABLE TO SIGNIFICANTLY PROLONG ALLOGENEIC
JRNL TITL 3 ORGAN ENGRAFTMENT IN VIVO.
JRNL REF J. MED. CHEM. V. 61 6705 2018
JRNL REFN ISSN 1520-4804
JRNL PMID 29952567
JRNL DOI 10.1021/ACS.JMEDCHEM.8B00521
REMARK 2
REMARK 2 RESOLUTION. 2.77 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.77
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 86.42
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0
REMARK 3 NUMBER OF REFLECTIONS : 742
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING + TEST SET) : 0.278
REMARK 3 R VALUE (WORKING SET) : 0.276
REMARK 3 FREE R VALUE : 0.333
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 5288
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 30
REMARK 3 SOLVENT ATOMS : 15
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): NULL
REMARK 3 ESU BASED ON FREE R VALUE (A): NULL
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6GL3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-MAY-18.
REMARK 100 THE DEPOSITION ID IS D_1200010167.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 30-OCT-13
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X06DA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19839
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.770
REMARK 200 RESOLUTION RANGE LOW (A) : 86.420
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0
REMARK 200 DATA REDUNDANCY : 2.800
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.0500
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.77
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.84
REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9
REMARK 200 DATA REDUNDANCY IN SHELL : 2.80
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.720
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 44.09
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CITRATE, 22% (W/V)
REMARK 280 PEG3350, 10 MM MANGANESE(II)CHLORIDE, VAPOR DIFFUSION, HANGING
REMARK 280 DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.23400
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.42000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.74200
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 86.42000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.23400
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.74200
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 316
REMARK 465 SER A 317
REMARK 465 SER A 318
REMARK 465 PRO A 319
REMARK 465 VAL A 320
REMARK 465 ARG A 321
REMARK 465 LEU A 322
REMARK 465 ARG A 519
REMARK 465 ILE A 520
REMARK 465 ARG A 521
REMARK 465 SER A 522
REMARK 465 THR A 523
REMARK 465 ARG A 524
REMARK 465 SER A 525
REMARK 465 ASP A 526
REMARK 465 SER A 527
REMARK 465 GLY A 528
REMARK 465 ASP A 529
REMARK 465 GLY A 530
REMARK 465 SER A 531
REMARK 465 ALA A 532
REMARK 465 LEU A 533
REMARK 465 LYS A 534
REMARK 465 SER A 697
REMARK 465 PRO A 698
REMARK 465 ARG A 699
REMARK 465 ASN A 700
REMARK 465 LEU A 701
REMARK 465 GLY A 702
REMARK 465 PHE A 703
REMARK 465 GLU A 704
REMARK 465 ARG A 798
REMARK 465 GLY B 316
REMARK 465 SER B 317
REMARK 465 SER B 318
REMARK 465 PRO B 319
REMARK 465 VAL B 320
REMARK 465 ARG B 321
REMARK 465 LEU B 322
REMARK 465 ALA B 323
REMARK 465 PRO B 324
REMARK 465 GLU B 325
REMARK 465 ARG B 326
REMARK 465 GLU B 327
REMARK 465 GLY B 336
REMARK 465 LYS B 337
REMARK 465 ARG B 338
REMARK 465 LEU B 339
REMARK 465 ALA B 340
REMARK 465 THR B 341
REMARK 465 LYS B 345
REMARK 465 GLU B 346
REMARK 465 GLN B 347
REMARK 465 LYS B 348
REMARK 465 THR B 349
REMARK 465 GLN B 350
REMARK 465 ARG B 351
REMARK 465 LEU B 352
REMARK 465 ILE B 353
REMARK 465 SER B 354
REMARK 465 GLU B 355
REMARK 465 LEU B 356
REMARK 465 SER B 357
REMARK 465 LEU B 358
REMARK 465 LEU B 359
REMARK 465 ASN B 360
REMARK 465 VAL B 387
REMARK 465 VAL B 388
REMARK 465 LEU B 389
REMARK 465 ASN B 390
REMARK 465 SER B 391
REMARK 465 LYS B 392
REMARK 465 ASP B 393
REMARK 465 ASP B 410
REMARK 465 THR B 411
REMARK 465 THR B 412
REMARK 465 ALA B 513
REMARK 465 ARG B 514
REMARK 465 ILE B 515
REMARK 465 PRO B 516
REMARK 465 GLU B 517
REMARK 465 ASN B 518
REMARK 465 ARG B 519
REMARK 465 ILE B 520
REMARK 465 ARG B 521
REMARK 465 SER B 522
REMARK 465 THR B 523
REMARK 465 ARG B 524
REMARK 465 SER B 525
REMARK 465 ASP B 526
REMARK 465 SER B 527
REMARK 465 GLY B 528
REMARK 465 ASP B 529
REMARK 465 GLY B 530
REMARK 465 SER B 531
REMARK 465 ALA B 532
REMARK 465 LEU B 533
REMARK 465 LYS B 534
REMARK 465 GLU B 535
REMARK 465 PRO B 612
REMARK 465 VAL B 613
REMARK 465 VAL B 614
REMARK 465 ASN B 615
REMARK 465 GLY B 639
REMARK 465 SER B 640
REMARK 465 SER B 695
REMARK 465 SER B 696
REMARK 465 SER B 697
REMARK 465 PRO B 698
REMARK 465 ARG B 699
REMARK 465 ASN B 700
REMARK 465 LEU B 701
REMARK 465 GLY B 702
REMARK 465 PHE B 703
REMARK 465 GLU B 704
REMARK 465 THR B 705
REMARK 465 SER B 706
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 LYS A 330 CE NZ
REMARK 480 LYS A 337 CE NZ
REMARK 480 GLU A 346 CD OE1 OE2
REMARK 480 LEU A 358 CG CD1 CD2
REMARK 480 LYS A 362 CE NZ
REMARK 480 LYS A 392 CG CD CE NZ
REMARK 480 ASP A 393 CG OD1 OD2
REMARK 480 LYS A 394 CG CD CE NZ
REMARK 480 GLN A 538 CD OE1 NE2
REMARK 480 LYS A 540 NZ
REMARK 480 ARG A 542 NE CZ NH1 NH2
REMARK 480 LYS A 564 NZ
REMARK 480 GLN A 588 CG CD OE1 NE2
REMARK 480 ARG A 590 CG CD NE CZ NH1 NH2
REMARK 480 LYS A 596 NZ
REMARK 480 GLN A 621 CD OE1 NE2
REMARK 480 GLN A 625 CG CD OE1 NE2
REMARK 480 GLU A 644 CG CD OE1 OE2
REMARK 480 LYS A 670 CD CE NZ
REMARK 480 SER A 695 OG
REMARK 480 LYS A 709 CE NZ
REMARK 480 ASP A 722 CG OD1 OD2
REMARK 480 ASP A 724 CG OD1 OD2
REMARK 480 ASN A 727 CG OD1 ND2
REMARK 480 LYS A 730 CD CE NZ
REMARK 480 LEU A 734 CD1 CD2
REMARK 480 LYS A 742 CD CE NZ
REMARK 480 ASP A 745 CG OD1 OD2
REMARK 480 LYS A 746 CG CD CE NZ
REMARK 480 VAL A 747 CG1 CG2
REMARK 480 ILE A 753 CD1
REMARK 480 SER A 758 OG
REMARK 480 GLN A 759 CG CD OE1 NE2
REMARK 480 LEU A 760 CG CD1 CD2
REMARK 480 HIS A 764 CG ND1 CD2 CE1 NE2
REMARK 480 SER A 766 OG
REMARK 480 ARG A 770 CG CD NE CZ NH1 NH2
REMARK 480 LYS A 773 CG CD CE NZ
REMARK 480 GLU A 774 CG CD OE1 OE2
REMARK 480 GLU A 783 CG CD OE1 OE2
REMARK 480 GLN A 784 CG CD OE1 NE2
REMARK 480 GLN A 786 CG CD OE1 NE2
REMARK 480 LEU A 787 CD1 CD2
REMARK 480 LEU A 788 CG CD1 CD2
REMARK 480 ILE B 329 CG1 CG2 CD1
REMARK 480 LYS B 330 CG CD CE NZ
REMARK 480 MET B 333 CG SD CE
REMARK 480 ILE B 335 CG1 CG2 CD1
REMARK 480 ARG B 366 CG CD NE CZ NH1 NH2
REMARK 480 TRP B 368 CG CD1 CD2 NE1 CE2 CE3 CZ2
REMARK 480 TRP B 368 CZ3 CH2
REMARK 480 HIS B 383 CG ND1 CD2 CE1 NE2
REMARK 480 ILE B 399 CG1 CG2 CD1
REMARK 480 VAL B 401 CG1 CG2
REMARK 480 LEU B 404 CG CD1 CD2
REMARK 480 GLU B 405 CG CD OE1 OE2
REMARK 480 GLU B 407 CG CD OE1 OE2
REMARK 480 ASN B 408 CG OD1 ND2
REMARK 480 GLU B 539 CG CD OE1 OE2
REMARK 480 LYS B 540 CG CD CE NZ
REMARK 480 VAL B 541 CG1 CG2
REMARK 480 ARG B 542 CG CD NE CZ NH1 NH2
REMARK 480 LYS B 564 CG CD CE NZ
REMARK 480 LEU B 569 CG CD1 CD2
REMARK 480 LYS B 580 CG CD CE NZ
REMARK 480 GLN B 581 CG CD OE1 NE2
REMARK 480 ILE B 585 CD1
REMARK 480 GLU B 587 CD OE1 OE2
REMARK 480 GLN B 588 CG CD OE1 NE2
REMARK 480 ARG B 590 CG CD NE CZ NH1 NH2
REMARK 480 LYS B 596 CD CE NZ
REMARK 480 LYS B 599 CG CD CE NZ
REMARK 480 GLN B 621 CG CD OE1 NE2
REMARK 480 LYS B 624 CG CD CE NZ
REMARK 480 GLN B 625 CD OE1 NE2
REMARK 480 LEU B 635 CG CD1 CD2
REMARK 480 GLN B 636 CD OE1 NE2
REMARK 480 GLU B 637 CD OE1 OE2
REMARK 480 TYR B 641 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 480 THR B 642 OG1 CG2
REMARK 480 GLU B 644 CG CD OE1 OE2
REMARK 480 LEU B 647 CG CD1 CD2
REMARK 480 LYS B 670 CE NZ
REMARK 480 LEU B 679 CG CD1 CD2
REMARK 480 PHE B 692 CG CD1 CD2 CE1 CE2 CZ
REMARK 480 LYS B 709 CG CD CE NZ
REMARK 480 LEU B 721 CG CD1 CD2
REMARK 480 ASP B 724 CG OD1 OD2
REMARK 480 MET B 725 CG SD CE
REMARK 480 ASN B 727 CG OD1 ND2
REMARK 480 GLN B 735 CG CD OE1 NE2
REMARK 480 ILE B 738 CG1 CG2 CD1
REMARK 480 LYS B 742 CG CD CE NZ
REMARK 480 LYS B 746 CD CE NZ
REMARK 480 VAL B 747 CG1 CG2
REMARK 480 LEU B 760 CG CD1 CD2
REMARK 480 LYS B 773 CG CD CE NZ
REMARK 480 GLU B 783 CG CD OE1 OE2
REMARK 480 GLN B 786 CG CD OE1 NE2
REMARK 480 LEU B 787 CG CD1 CD2
REMARK 480 LEU B 788 CG CD1 CD2
REMARK 480 GLU B 790 CG CD OE1 OE2
REMARK 480 MET B 792 CG SD CE
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 TYR B 641 CB - CG - CD2 ANGL. DEV. = 4.6 DEGREES
REMARK 500 TYR B 641 CB - CG - CD1 ANGL. DEV. = -4.7 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 393 -64.68 -103.57
REMARK 500 ALA A 395 75.30 -115.20
REMARK 500 PRO A 592 44.02 -88.35
REMARK 500 ASP A 689 63.55 61.50
REMARK 500 PHE A 690 45.92 -82.96
REMARK 500 LEU A 694 -127.06 60.68
REMARK 500 SER A 706 15.56 56.61
REMARK 500 GLN A 759 69.04 -117.02
REMARK 500 HIS A 764 50.53 -90.49
REMARK 500 HIS A 777 63.44 60.20
REMARK 500 CYS B 565 147.67 -170.20
REMARK 500 PRO B 592 45.03 -88.37
REMARK 500 ASP B 689 63.61 60.59
REMARK 500 PHE B 690 46.05 -82.80
REMARK 500 MET B 797 63.58 -101.11
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EMW A 801
DBREF 6GL3 A 317 525 UNP Q9UBF8 PI4KB_HUMAN 317 428
DBREF 6GL3 A 532 798 UNP Q9UBF8 PI4KB_HUMAN 532 798
DBREF 6GL3 B 317 525 UNP Q9UBF8 PI4KB_HUMAN 317 428
DBREF 6GL3 B 532 798 UNP Q9UBF8 PI4KB_HUMAN 532 798
SEQADV 6GL3 GLY A 316 UNP Q9UBF8 EXPRESSION TAG
SEQADV 6GL3 ASP A 526 UNP Q9UBF8 LINKER
SEQADV 6GL3 SER A 527 UNP Q9UBF8 LINKER
SEQADV 6GL3 GLY A 528 UNP Q9UBF8 LINKER
SEQADV 6GL3 ASP A 529 UNP Q9UBF8 LINKER
SEQADV 6GL3 GLY A 530 UNP Q9UBF8 LINKER
SEQADV 6GL3 SER A 531 UNP Q9UBF8 LINKER
SEQADV 6GL3 GLY B 316 UNP Q9UBF8 EXPRESSION TAG
SEQADV 6GL3 ASP B 526 UNP Q9UBF8 LINKER
SEQADV 6GL3 SER B 527 UNP Q9UBF8 LINKER
SEQADV 6GL3 GLY B 528 UNP Q9UBF8 LINKER
SEQADV 6GL3 ASP B 529 UNP Q9UBF8 LINKER
SEQADV 6GL3 GLY B 530 UNP Q9UBF8 LINKER
SEQADV 6GL3 SER B 531 UNP Q9UBF8 LINKER
SEQRES 1 A 386 GLY SER SER PRO VAL ARG LEU ALA PRO GLU ARG GLU PHE
SEQRES 2 A 386 ILE LYS SER LEU MET ALA ILE GLY LYS ARG LEU ALA THR
SEQRES 3 A 386 LEU PRO THR LYS GLU GLN LYS THR GLN ARG LEU ILE SER
SEQRES 4 A 386 GLU LEU SER LEU LEU ASN HIS LYS LEU PRO ALA ARG VAL
SEQRES 5 A 386 TRP LEU PRO THR ALA GLY PHE ASP HIS HIS VAL VAL ARG
SEQRES 6 A 386 VAL PRO HIS THR GLN ALA VAL VAL LEU ASN SER LYS ASP
SEQRES 7 A 386 LYS ALA PRO TYR LEU ILE TYR VAL GLU VAL LEU GLU CYS
SEQRES 8 A 386 GLU ASN PHE ASP THR THR SER VAL PRO ALA ARG ILE PRO
SEQRES 9 A 386 GLU ASN ARG ILE ARG SER THR ARG SER ASP SER GLY ASP
SEQRES 10 A 386 GLY SER ALA LEU LYS GLU PRO TRP GLN GLU LYS VAL ARG
SEQRES 11 A 386 ARG ILE ARG GLU GLY SER PRO TYR GLY HIS LEU PRO ASN
SEQRES 12 A 386 TRP ARG LEU LEU SER VAL ILE VAL LYS CYS GLY ASP ASP
SEQRES 13 A 386 LEU ARG GLN GLU LEU LEU ALA PHE GLN VAL LEU LYS GLN
SEQRES 14 A 386 LEU GLN SER ILE TRP GLU GLN GLU ARG VAL PRO LEU TRP
SEQRES 15 A 386 ILE LYS PRO TYR LYS ILE LEU VAL ILE SER ALA ASP SER
SEQRES 16 A 386 GLY MET ILE GLU PRO VAL VAL ASN ALA VAL SER ILE HIS
SEQRES 17 A 386 GLN VAL LYS LYS GLN SER GLN LEU SER LEU LEU ASP TYR
SEQRES 18 A 386 PHE LEU GLN GLU HIS GLY SER TYR THR THR GLU ALA PHE
SEQRES 19 A 386 LEU SER ALA GLN ARG ASN PHE VAL GLN SER CYS ALA GLY
SEQRES 20 A 386 TYR CYS LEU VAL CYS TYR LEU LEU GLN VAL LYS ASP ARG
SEQRES 21 A 386 HIS ASN GLY ASN ILE LEU LEU ASP ALA GLU GLY HIS ILE
SEQRES 22 A 386 ILE HIS ILE ASP PHE GLY PHE ILE LEU SER SER SER PRO
SEQRES 23 A 386 ARG ASN LEU GLY PHE GLU THR SER ALA PHE LYS LEU THR
SEQRES 24 A 386 THR GLU PHE VAL ASP VAL MET GLY GLY LEU ASP GLY ASP
SEQRES 25 A 386 MET PHE ASN TYR TYR LYS MET LEU MET LEU GLN GLY LEU
SEQRES 26 A 386 ILE ALA ALA ARG LYS HIS MET ASP LYS VAL VAL GLN ILE
SEQRES 27 A 386 VAL GLU ILE MET GLN GLN GLY SER GLN LEU PRO CYS PHE
SEQRES 28 A 386 HIS GLY SER SER THR ILE ARG ASN LEU LYS GLU ARG PHE
SEQRES 29 A 386 HIS MET SER MET THR GLU GLU GLN LEU GLN LEU LEU VAL
SEQRES 30 A 386 GLU GLN MET VAL ASP GLY SER MET ARG
SEQRES 1 B 386 GLY SER SER PRO VAL ARG LEU ALA PRO GLU ARG GLU PHE
SEQRES 2 B 386 ILE LYS SER LEU MET ALA ILE GLY LYS ARG LEU ALA THR
SEQRES 3 B 386 LEU PRO THR LYS GLU GLN LYS THR GLN ARG LEU ILE SER
SEQRES 4 B 386 GLU LEU SER LEU LEU ASN HIS LYS LEU PRO ALA ARG VAL
SEQRES 5 B 386 TRP LEU PRO THR ALA GLY PHE ASP HIS HIS VAL VAL ARG
SEQRES 6 B 386 VAL PRO HIS THR GLN ALA VAL VAL LEU ASN SER LYS ASP
SEQRES 7 B 386 LYS ALA PRO TYR LEU ILE TYR VAL GLU VAL LEU GLU CYS
SEQRES 8 B 386 GLU ASN PHE ASP THR THR SER VAL PRO ALA ARG ILE PRO
SEQRES 9 B 386 GLU ASN ARG ILE ARG SER THR ARG SER ASP SER GLY ASP
SEQRES 10 B 386 GLY SER ALA LEU LYS GLU PRO TRP GLN GLU LYS VAL ARG
SEQRES 11 B 386 ARG ILE ARG GLU GLY SER PRO TYR GLY HIS LEU PRO ASN
SEQRES 12 B 386 TRP ARG LEU LEU SER VAL ILE VAL LYS CYS GLY ASP ASP
SEQRES 13 B 386 LEU ARG GLN GLU LEU LEU ALA PHE GLN VAL LEU LYS GLN
SEQRES 14 B 386 LEU GLN SER ILE TRP GLU GLN GLU ARG VAL PRO LEU TRP
SEQRES 15 B 386 ILE LYS PRO TYR LYS ILE LEU VAL ILE SER ALA ASP SER
SEQRES 16 B 386 GLY MET ILE GLU PRO VAL VAL ASN ALA VAL SER ILE HIS
SEQRES 17 B 386 GLN VAL LYS LYS GLN SER GLN LEU SER LEU LEU ASP TYR
SEQRES 18 B 386 PHE LEU GLN GLU HIS GLY SER TYR THR THR GLU ALA PHE
SEQRES 19 B 386 LEU SER ALA GLN ARG ASN PHE VAL GLN SER CYS ALA GLY
SEQRES 20 B 386 TYR CYS LEU VAL CYS TYR LEU LEU GLN VAL LYS ASP ARG
SEQRES 21 B 386 HIS ASN GLY ASN ILE LEU LEU ASP ALA GLU GLY HIS ILE
SEQRES 22 B 386 ILE HIS ILE ASP PHE GLY PHE ILE LEU SER SER SER PRO
SEQRES 23 B 386 ARG ASN LEU GLY PHE GLU THR SER ALA PHE LYS LEU THR
SEQRES 24 B 386 THR GLU PHE VAL ASP VAL MET GLY GLY LEU ASP GLY ASP
SEQRES 25 B 386 MET PHE ASN TYR TYR LYS MET LEU MET LEU GLN GLY LEU
SEQRES 26 B 386 ILE ALA ALA ARG LYS HIS MET ASP LYS VAL VAL GLN ILE
SEQRES 27 B 386 VAL GLU ILE MET GLN GLN GLY SER GLN LEU PRO CYS PHE
SEQRES 28 B 386 HIS GLY SER SER THR ILE ARG ASN LEU LYS GLU ARG PHE
SEQRES 29 B 386 HIS MET SER MET THR GLU GLU GLN LEU GLN LEU LEU VAL
SEQRES 30 B 386 GLU GLN MET VAL ASP GLY SER MET ARG
HET EMW A 801 30
HETNAM EMW (3~{S})-4-(6-AZANYL-1-METHYL-PYRAZOLO[3,4-D]PYRIMIDIN-
HETNAM 2 EMW 4-YL)-~{N}-(4-METHOXY-2-METHYL-PHENYL)-3-METHYL-
HETNAM 3 EMW PIPERAZINE-1-CARBOXAMIDE
FORMUL 3 EMW C20 H26 N8 O2
FORMUL 4 HOH *15(H2 O)
HELIX 1 AA1 ALA A 323 GLU A 325 5 3
HELIX 2 AA2 ARG A 326 ALA A 340 1 15
HELIX 3 AA3 THR A 344 ASN A 360 1 17
HELIX 4 AA4 PRO A 382 ALA A 386 5 5
HELIX 5 AA5 PRO A 536 SER A 548 1 13
HELIX 6 AA6 LEU A 569 GLU A 589 1 21
HELIX 7 AA7 ILE A 619 GLN A 627 1 9
HELIX 8 AA8 SER A 629 HIS A 638 1 10
HELIX 9 AA9 THR A 643 GLN A 668 1 26
HELIX 10 AB1 THR A 711 MET A 718 1 8
HELIX 11 AB2 GLY A 723 HIS A 743 1 21
HELIX 12 AB3 HIS A 743 GLN A 756 1 14
HELIX 13 AB4 SER A 766 ARG A 775 1 10
HELIX 14 AB5 THR A 781 MET A 797 1 17
HELIX 15 AB6 ILE B 329 ILE B 335 1 7
HELIX 16 AB7 TRP B 537 SER B 548 1 12
HELIX 17 AB8 LEU B 569 GLU B 589 1 21
HELIX 18 AB9 ILE B 619 GLN B 627 1 9
HELIX 19 AC1 SER B 629 HIS B 638 1 10
HELIX 20 AC2 THR B 643 GLN B 668 1 26
HELIX 21 AC3 THR B 711 MET B 718 1 8
HELIX 22 AC4 GLY B 723 HIS B 743 1 21
HELIX 23 AC5 HIS B 743 GLN B 756 1 14
HELIX 24 AC6 PRO B 761 ARG B 775 1 15
HELIX 25 AC7 THR B 781 MET B 797 1 17
SHEET 1 AA1 3 HIS A 376 ARG A 380 0
SHEET 2 AA1 3 TYR A 397 GLU A 405 -1 O GLU A 402 N ARG A 380
SHEET 3 AA1 3 VAL A 387 VAL A 388 -1 N VAL A 387 O LEU A 398
SHEET 1 AA2 5 HIS A 376 ARG A 380 0
SHEET 2 AA2 5 TYR A 397 GLU A 405 -1 O GLU A 402 N ARG A 380
SHEET 3 AA2 5 TRP A 556 CYS A 565 -1 O VAL A 563 N TYR A 397
SHEET 4 AA2 5 SER A 607 ILE A 610 -1 O ILE A 610 N ILE A 562
SHEET 5 AA2 5 ILE A 600 SER A 604 -1 N LEU A 601 O MET A 609
SHEET 1 AA3 3 ALA A 616 SER A 618 0
SHEET 2 AA3 3 ILE A 677 ASP A 680 -1 O LEU A 679 N VAL A 617
SHEET 3 AA3 3 ILE A 685 HIS A 687 -1 O ILE A 686 N LEU A 678
SHEET 1 AA4 5 HIS B 376 ARG B 380 0
SHEET 2 AA4 5 TYR B 397 GLU B 405 -1 O GLU B 402 N ARG B 380
SHEET 3 AA4 5 TRP B 556 VAL B 563 -1 O VAL B 563 N TYR B 397
SHEET 4 AA4 5 SER B 607 ILE B 610 -1 O ILE B 610 N ILE B 562
SHEET 5 AA4 5 ILE B 600 SER B 604 -1 N LEU B 601 O MET B 609
SHEET 1 AA5 3 VAL B 617 SER B 618 0
SHEET 2 AA5 3 ILE B 677 LEU B 679 -1 O LEU B 679 N VAL B 617
SHEET 3 AA5 3 ILE B 685 HIS B 687 -1 O ILE B 686 N LEU B 678
CISPEP 1 LEU A 363 PRO A 364 0 -2.94
CISPEP 2 LEU B 363 PRO B 364 0 -1.08
SITE 1 AC1 13 ASN A 390 GLU A 405 ARG A 557 ILE A 562
SITE 2 AC1 13 TYR A 598 GLU A 611 PRO A 612 VAL A 613
SITE 3 AC1 13 ALA A 616 HIS A 620 GLY A 675 LEU A 678
SITE 4 AC1 13 ILE A 688
CRYST1 64.468 69.484 172.840 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015512 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014392 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005786 0.00000